May 12, 2020 – 2 pm ET

Reimagining the Global Pharmaceutical Supply Chain

William Fleming, President, Clinical and Pharmacy Solutions, Healthcare Services, Humana Inc.
Ammie McAsey, Senior Vice President, Distribution Operations, US Pharma, McKesson Pharmaceutical Solutions and Services
Richard Saynor, Chief Executive Officer, Global, Sandoz
Moderator: Ian Spatz, Senior Advisor, Manatt Health

Benefiting: Save the Children

View Details

The COVID-19 pandemic has brought forth important considerations for the global pharmaceutical supply chain. New realities present challenges and opportunities that will undoubtedly lead to dramatic changes in the way we do business in the future. Our panel will share their perspectives on the most likely scenarios for how companies and industries will adapt and grow in response to the pandemic.

May 20, 2020 – 12 pm ET

PBM Industry Response and Role During the COVID-19 Pandemic

Alan Lotvin, President, CVS Caremark and Executive Vice President, CVS Health and PCMA Chairman of the Board
JC Scott, President & Chief Executive Officer, PCMA
Moderator: Ian Spatz, Senior Advisor, Manatt Health

Benefiting: Feed the Fight

Date TBA

PBM Executive Panel: Current and Future Consideration’s for PBM-Pharma Relations

Speakers – PBM Supply Chain and Trade Relations Executives TBA

Date TBA

Pharma Executive Panel: Theme and Focus TBD

Speakers – Pharma Senior Executives TBA

Date TBA

US Drug Supply Chain Interoperability – Past, Present & Future

Speakers – TBA

Date TBA

Public and Private Sector Supply Chain Coordination – COVID-19 Lessons Learned, and Changes to Come

Speakers – TBA